Nuveen’s Vor Biopharma VOR Stock Holding History

Nuveen’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.75M	Buy	+94,815	New	+$1.43M	﹤0.01%	2641
2024 Q2	–	Sell	-3,575	Closed	-$169K	–	3421
2024 Q1	$169K	Hold	3,575	–	–	﹤0.01%	3209
2023 Q4	$161K	Hold	3,575	–	–	﹤0.01%	3243
2023 Q3	$152K	Hold	3,575	–	–	﹤0.01%	3079
2023 Q2	$221K	Buy	+3,575	New	+$326K	﹤0.01%	3078
2022 Q2	–	Sell	-2,765	Closed	-$422K	–	3492
2022 Q1	$422K	Buy	2,765 +53	+2%	+$9.02K	﹤0.01%	3061
2021 Q4	$666K	Sell	2,712 -214	-7%	-$61.7K	﹤0.01%	2992
2021 Q3	$899K	Buy	2,926 +516	+21%	+$153K	﹤0.01%	3027
2021 Q2	$899K	Buy	2,410 +334	+16%	+$165K	﹤0.01%	3047
2021 Q1	$1.79M	Buy	+2,076	New	+$1.76M	﹤0.01%	2668

Other funds holding VOR

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Nuveen's VOR Position: Q2 2026 in Review

Nuveen opened a new position in Vor Biopharma (VOR) in Q2 2026: 94,815 shares worth $1.75M. The stake represents ﹤0.01% of the portfolio and ranks #2641 among its holdings. This is a return to the name: Nuveen previously reported a position in VOR as recently as Q1 2024.

Nuveen first reported a position in VOR in Q1 2021 and has held it in 10 quarters since. The position peaked at $1.79M in Q1 2021. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

Nuveen held 94,815 shares of Vor Biopharma worth $1.75M as of Q2 2026.
Vor Biopharma was a new Nuveen position in Q2 2026.
Vor Biopharma made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2641 holding.
Nuveen first reported a position in Vor Biopharma in Q1 2021 and has held it in 10 quarters since.
Nuveen's Vor Biopharma position peaked at $1.79M in Q1 2021.
102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.